
繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
立即開戶
Veeva Systems | 10-Q: Q3 2025 Earnings Report
Veeva Systems | 10-Q: Q3 2025 Earnings Report
Veeva Systems | 10-Q:2025財年三季報
牛牛AI助理已提取核心訊息
Veeva Systems reported strong Q3 FY2025 results with total revenues increasing 13% year-over-year to $699.2 million. Subscription services revenue grew 17% to $580.9 million, driven by a 24% increase in R&D Solutions revenue, while professional services revenue declined 3% to $118.4 million. Operating income rose 41% to $181.4 million with a 26% operating margin.The company saw continued momentum in its R&D Solutions segment, which contributed 52% of subscription revenues as life sciences companies expanded their use of Veeva Development Cloud products. Commercial Solutions revenue grew moderately, up 11% year-over-year, benefiting from increased adoption of Veeva Commercial Cloud products and annual price adjustments.Management highlighted plans to migrate CRM customers to the new Vault CRM platform by 2030, while maintaining support for the existing Salesforce-based solution until then. The company's cash position remained strong with $5.1 billion in cash and investments. Looking ahead, Veeva expects revenue growth to accelerate in FY2025 compared to FY2024, though noting some continued scrutiny on professional services projects.
Veeva Systems reported strong Q3 FY2025 results with total revenues increasing 13% year-over-year to $699.2 million. Subscription services revenue grew 17% to $580.9 million, driven by a 24% increase in R&D Solutions revenue, while professional services revenue declined 3% to $118.4 million. Operating income rose 41% to $181.4 million with a 26% operating margin.The company saw continued momentum in its R&D Solutions segment, which contributed 52% of subscription revenues as life sciences companies expanded their use of Veeva Development Cloud products. Commercial Solutions revenue grew moderately, up 11% year-over-year, benefiting from increased adoption of Veeva Commercial Cloud products and annual price adjustments.Management highlighted plans to migrate CRM customers to the new Vault CRM platform by 2030, while maintaining support for the existing Salesforce-based solution until then. The company's cash position remained strong with $5.1 billion in cash and investments. Looking ahead, Veeva expects revenue growth to accelerate in FY2025 compared to FY2024, though noting some continued scrutiny on professional services projects.
Veeva Systems報告了強勁的2025財年第三季度業績,總營業收入同比增長13%,達到69920萬美元。訂閱服務收入增長17%,達到58090萬美元,主要得益於研發解決方案收入增長24%;而專業服務收入則下降3%,爲11840萬美元。營業收入增長41%,達到18140萬美元,營業利潤率爲26%。公司在其研發解決方案領域保持持續增長,該領域貢獻了52%的訂閱收入,因爲生命科學公司擴大了對Veeva Development Cloud產品的使用。商業解決方案的收入也適度增長,同比上升11%,受益於Veeva Commercial Cloud產品的更多采用和年度價格調整。管理層強調計劃在20...展開全部
Veeva Systems報告了強勁的2025財年第三季度業績,總營業收入同比增長13%,達到69920萬美元。訂閱服務收入增長17%,達到58090萬美元,主要得益於研發解決方案收入增長24%;而專業服務收入則下降3%,爲11840萬美元。營業收入增長41%,達到18140萬美元,營業利潤率爲26%。公司在其研發解決方案領域保持持續增長,該領域貢獻了52%的訂閱收入,因爲生命科學公司擴大了對Veeva Development Cloud產品的使用。商業解決方案的收入也適度增長,同比上升11%,受益於Veeva Commercial Cloud產品的更多采用和年度價格調整。管理層強調計劃在2030年前將客戶關係管理(CRm)客戶遷移至新的Vault CRm平台,同時在此之前繼續支持現有的基於賽富時的解決方案。公司的現金狀況依然強勁,現金和投資總額爲51億美元。展望未來,Veeva預計2025財年的營業收入增長將比2024財年加速,儘管仍需注意對專業服務項目的持續審查。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
相關股票 相關股票
投資課程

看財報揀好股
快速掌握財報季學習指引
財報季來臨,公司股價最易大升大跌,很多優秀的投資者會將財報季視為“大賺一筆”的好時機。 假設你現在持有某隻股票,該公司發佈財報後股價跳水,大跌10%,此時你會怎麼做? 短期波動不改長期增長邏輯,堅定持有 財報業績不及預期,馬上賣掉止盈止損 未來可能還要跌,賣掉之後反手做空 具體如何選擇?取決於我們是什麼類型的投資者,也
【2025.1】特斯拉業績怎麽看?關註這四個重點
又到了美股業績期。而巨頭公司的業績,不但會影響自己的股價,甚至還會影響整個美股市場的走勢,其中也可能蘊含著交易機會。 那麼,這些巨頭公司的業績該怎麼看呢?今天我們聚焦特斯拉,看看特斯拉的業績有哪些關鍵因素,可能會對股價帶來什麼明顯影響…… 1、銷量變化 首先,對新能源車企來說,最重要的觀察指標始終是總交付量, 或者說銷
【2024.11】60年上漲超4萬倍,成就股神巴菲特之名!伯克希爾的業績怎麼看?
要說到投資界的傳奇人物, $伯克希尔-B (BRK.B.US)$ 的掌舵者沃倫.巴菲特,一定是一個繞不開的名字。伯克希爾在1965-2023年期間高達4.38萬倍的回報,也成就了巴菲特的股神之名。伯克希爾公司的一些重大動作,也牽動着資本市場的神經,成爲市場風向標之一。 伯克希爾每次業績的發佈,自然也成爲市場關注的重中之